Texas biotech facility in College Station tapped to mass-produce potential COVID-19 vaccine
Source: Texas Tribune
A biotech production facility in College Station could begin manufacturing hundreds of millions of doses of a COVID-19 vaccine as early as next year.
As part of a $265 million contract with the federal government, the Texas A&M University System Center for Innovation in Advanced Development and Manufacturing — which is owned and operated by Fujifilm Diosynth Biotechnologies — has been tapped to mass-manufacture a vaccine candidate that is still undergoing testing. That vaccine, which is being developed by the little-known Maryland company Novavax, is one of six candidates the federal government has put billions of dollars behind as part of its Operation Warp Speed, which is pursuing an aggressive timeline for mass-distributing a coronavirus vaccine.
President Donald Trump, appearing Monday afternoon at a North Carolina Fujifilm facility where the vaccine candidate is being developed for clinical trials, praised the progress of the Novavax vaccine and of other therapeutics.
“We will have it delivered in record time,” he said.
Read more: https://www.texastribune.org/2020/07/27/novavax-coronavirus-vaccine-texas/
= new reply since forum marked as read
